Eledon Historical Financial Ratios
| ELDN Stock | USD 4.52 0.26 5.44% |
Eledon Pharmaceuticals is recently reporting on over 88 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 5.8 K or Days Sales Outstanding of 268 will help investors to properly organize and evaluate Eledon Pharmaceuticals financial condition quickly.
Eledon |
About Eledon Financial Ratios Analysis
Eledon PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Eledon Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Eledon financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Eledon Pharmaceuticals history.
Eledon Pharmaceuticals Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Eledon Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Eledon Pharmaceuticals sales, a figure that is much harder to manipulate than other Eledon Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Eledon Pharmaceuticals dividend as a percentage of Eledon Pharmaceuticals stock price. Eledon Pharmaceuticals dividend yield is a measure of Eledon Pharmaceuticals stock productivity, which can be interpreted as interest rate earned on an Eledon Pharmaceuticals investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from Eledon Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Eledon Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eledon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.At this time, Eledon Pharmaceuticals' Price Earnings To Growth Ratio is very stable compared to the past year.
| 2010 | 2024 | 2025 (projected) | Dividend Yield | 0.001118 | 0.001007 | 8.94E-4 | Price To Sales Ratio | 186.27 | 167.64 | 149.02 |
Eledon Pharmaceuticals fundamentals Correlations
Click cells to compare fundamentals
Eledon Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Eledon Pharmaceuticals fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 0.12 | 0.4 | 0.39 | 6.1K | 5.5K | 5.8K | |
| Book Value Per Share | 131.32 | 11.07 | 5.89 | 2.93E-4 | 3.37E-4 | 3.2E-4 | |
| Free Cash Flow Yield | (0.68) | (0.44) | (0.87) | (8.92E-4) | (8.03E-4) | (8.43E-4) | |
| Operating Cash Flow Per Share | (10.48) | (1.95) | (1.99) | (0.001606) | (0.001445) | (0.001517) | |
| Pb Ratio | 0.12 | 0.4 | 0.39 | 6.1K | 5.5K | 5.8K | |
| Free Cash Flow Per Share | (10.48) | (1.95) | (1.99) | (0.001606) | (0.001445) | (0.001517) | |
| Roic | (0.093) | (0.21) | 0.0971 | (0.5) | (0.45) | (0.47) | |
| Net Income Per Share | (15.72) | (2.33) | (6.13) | (0.001638) | (0.001474) | (0.001548) | |
| Payables Turnover | 0.13 | 0.11 | 0.17 | 0.39 | 0.35 | 0.37 | |
| Cash Per Share | 78.68 | 5.72 | 3.95 | 0.002076 | 0.002387 | 0.002268 | |
| Pocfratio | (1.47) | (2.26) | (1.15) | (1.1K) | (1.3K) | (1.2K) | |
| Pfcf Ratio | (1.47) | (2.26) | (1.15) | (1.1K) | (1.3K) | (1.2K) | |
| Days Payables Outstanding | 2.7K | 3.4K | 2.2K | 943.73 | 1.1K | 1.0K | |
| Income Quality | 0.67 | 0.84 | 0.32 | 0.34 | 0.39 | 0.37 | |
| Roe | (0.12) | (0.21) | (1.04) | (5.59) | (6.43) | (6.11) | |
| Ev To Operating Cash Flow | 6.03 | 0.65 | 0.81 | (1.1K) | (1.3K) | (1.2K) | |
| Pe Ratio | (0.98) | (1.89) | (0.37) | (1.1K) | (1.3K) | (1.2K) | |
| Return On Tangible Assets | (0.2) | (0.39) | (1.45) | (0.71) | (0.82) | (0.86) | |
| Ev To Free Cash Flow | 6.03 | 0.65 | 0.81 | (1.1K) | (1.3K) | (1.2K) | |
| Earnings Yield | (1.02) | (0.53) | (2.69) | (9.1E-4) | (0.001046) | (0.001099) | |
| Current Ratio | 46.57 | 20.07 | 9.19 | 14.41 | 12.97 | 12.26 | |
| Tangible Book Value Per Share | 75.49 | 5.6 | 3.63 | (0.001023) | (0.001176) | (0.001117) | |
| Graham Number | 215.49 | 24.08 | 28.5 | 0.003285 | 0.003778 | 0.003589 | |
| Shareholders Equity Per Share | 131.32 | 11.07 | 5.89 | 2.93E-4 | 3.37E-4 | 3.2E-4 | |
| Debt To Equity | 7.56E-4 | 0.004689 | 0.008862 | 0.0531 | 0.0611 | 0.0421 | |
| Graham Net Net | 74.64 | 5.28 | 3.35 | (0.001249) | (0.001437) | (0.001365) | |
| Interest Debt Per Share | 0.0992 | 0.0519 | 0.0522 | 1.6E-5 | 1.8E-5 | 1.7E-5 | |
| Debt To Assets | 7.3E-4 | 0.004509 | 0.008039 | 0.0043 | 0.004945 | 0.004698 | |
| Enterprise Value Over E B I T D A | 0.1 | 3.98 | 0.51 | 0.26 | 0.24 | 0.25 | |
| Price Earnings Ratio | (0.98) | (1.89) | (0.37) | (1.1K) | (1.3K) | (1.2K) | |
| Price Book Value Ratio | 0.12 | 0.4 | 0.39 | 6.1K | 5.5K | 5.8K | |
| Days Of Payables Outstanding | 2.7K | 3.4K | 2.2K | 943.73 | 1.1K | 1.0K | |
| Price To Operating Cash Flows Ratio | (1.47) | (2.26) | (1.15) | (1.1K) | (1.3K) | (1.2K) |
Pair Trading with Eledon Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eledon Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Eledon Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eledon Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eledon Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eledon Pharmaceuticals to buy it.
The correlation of Eledon Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eledon Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eledon Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eledon Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eledon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.